Key result
Male sex shows no difference in PE clot resolution at 3 weeks vs. female sex.
Why the study?
It was unknown whether differences in clot structure and resolution contribute to the reported risk differences of recurrent venous thromboembolism between men and women.
Are there sex-specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants?
Observational (n=371)
Blinded adjudication committee
Yes
Are there sex-specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants?
There are no sex-specific differences in clot resolution 3 weeks after acute pulmonary embolism, suggesting that the higher rate of VTE recurrence in men is not explained by decreased clot resolution.
Answers are grounded in this paper and cite their sources.
No sex-specific therapy adjustments indicated at 3 weeks post-PE; leaves open mechanisms for higher male VTE recurrence.
BACKGROUND: It is unknown whether differences in clot structure and resolution contribute to the reported risk differences of recurrent venous thromboembolism (VTE) between men and women. PATIENTS/METHODS: We used data from the EINSTEIN-PE study, a randomized, multicenter, non-inferiority study in which patients 18 years and older with acute symptomatic pulmonary embolism (PE) were randomized to rivaroxaban or enoxaparin followed by a vitamin K antagonist. PE was diagnosed by computed tomography pulmonary angiography scan or high-probability ventilation/perfusion scintigraphy. Three weeks after randomization a follow-up scan was performed. An independent adjudication committee assessed the degree of vascular obstruction. RESULTS AND CONCLUSIONS: A total of 371 participants including 174 (46.9%) women and 197 (53.0%) men were included in the present analysis. At 3 weeks, there was no difference between men and women in complete clot resolution: 39.6% and 40.2%, respectively. The absolute reduction in pulmonary vascular obstruction at week 3 was also similar: 12.9% (95% confidence interval [CI]: 11.6-14.2) in men and 12.1% (95% CI: 10.4-13.7) in women, corresponding to a resolution ratio of 0.29 (95% CI: 0.24-0.33) and 0.35 (95% CI: 0.28-0.42), respectively. No differences in clot resolution were observed between men and women diagnosed with acute PE at 3 weeks after start of anticoagulant therapy. These findings suggest that the reported higher rate of VTE recurrence in men cannot be explained by decreased clot resolution.
No takes yet. Share an insight, caveat, or question.
Wiegers et al. (2021) conducted an observational in Acute symptomatic pulmonary embolism (n=371). Male sex vs. Female sex was evaluated on Change in percentage of pulmonary vascular obstruction between baseline and week 3 (MD -0.1, 95% CI -1.6 to 1.3). Male sex was not associated with differences in the mean change of pulmonary vascular obstruction or complete clot resolution compared to female sex 3 weeks after starting anticoagulant therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: